LI Lan-xin,CHEN Xin-yu,CAI Hu-zhi.Clinical Efficacy of Midified Wendantang and Xueyaping Recipe in Middle Aged and Young People with Hypertension and Phlegm Dampness Retention[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(09):106-111.
LI Lan-xin,CHEN Xin-yu,CAI Hu-zhi.Clinical Efficacy of Midified Wendantang and Xueyaping Recipe in Middle Aged and Young People with Hypertension and Phlegm Dampness Retention[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(09):106-111. DOI: 10.13422/j.cnki.syfjx.20210233.
Clinical Efficacy of Midified Wendantang and Xueyaping Recipe in Middle Aged and Young People with Hypertension and Phlegm Dampness Retention
随机将120例患者按数字表法分为对照组和观察组。两组均口服富马酸比索洛尔片,5~10 mg/次,1次/d。对照组口服半夏天麻丸,6 g/次,2次/d;观察组给予温胆汤合血压平方加减内服,1剂/d。两组疗程均12周。进行家庭血压监测,记录治疗后血压达标情况;进行治疗前后动态血压监测,记录24 h平均舒张压(24 h DBP),24 h平均收缩压(24 h SBP),24 h 平均脉压(24 h PP)和血压变异性(BPV)指标[24 h收缩压标准差(24 h SSD),24 h舒张压标准差(24 h DSD),收缩压变异系数(nSCV),舒张压变异系数(nDCV),比较夜间系数];进行治疗前后痰湿壅盛证评分、体质量指数(BMI)和腰臀比(WHR)评价;检测治疗前后高密度脂蛋白胆固醇(HDL-C),尿酸(UA),总胆固醇(TC),空腹血糖(FBG),低密度脂蛋白胆固醇(LDL-C),甘油三酯(TG)和空腹胰岛素(FINS),并计算胰岛素抵抗指数(HOMA-IR);检测治疗前后同型半胱氨酸(Hcy),胱抑素C(CysC),血管紧张素Ⅱ(AngⅡ)和核转录因子-
κ
B(NF-
κ
B)水平。
结果
2
观察组血压达标率为94.74%(54/57),高于对照组的达标率为80.70%(46/57)(
χ
2
=5.211,
P
<
0.05);观察组24 h SBP,24 h DBP,24 h PP,24 h SSD,24 h DSD,nSCV,nDCV均低于对照组(
To discuss the clinical efficacy of modified Wendantang combined with Xueyaping recipe in the middle aged and young people with hypertension and syndrome of phlegm dampness accumulation, and investigate its effect on metabolism.
Method
2
One hundred and twenty patients were divided into control group and observation group averagely. Patients in both groups got lifestyle intervention and bisoprolol maleate tablets, 5-10 mg/time, 1 time/day. Patients in observation group additionally took modified Wendantang combined with Xueyaping recipe, 1 dose/day. Patients in control group addiiotnally got placebo granules Banxia Tianma Wan, 6 g/time, 2 times/day. The treatment was continued for 12 weeks in both groups. Blood pressure was measured at home to measure the compliance rate of blood pressure during the treatment and after the treatment. Before and after treatment, 24 h mean systolic blood pressure (24 h SBP), 24 h mean pulse pressure (24 h PP), 24 h mean diastolic blood pressure (24 h DBP), blood pressure variability (BPV) [24 h systolic blood pressure standard deviation (24 h SSD), 24 h diastolic blood pressure standard deviation (24 h DSD), systolic blood pressure variation coefficient (nSCV), and diastolic blood pressure variation coefficient (nDCV) were recorded,compare night coefficients]. Scores of syndrome of phlegm dampness accumulation, body mass index (BMI) and waist hip ratio (WHR) were evaluated. Levels of uric acid (UA), total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterin (HDL-C), low-density lipoprotein cholesterin (LDL-C), fasting blood glucose (FBG) and fasting insulin (FINS), insulin resistance index (HOMA-IR), homocysteine (Hcy), Cystatin C (CysC), angiotensin Ⅱ (Ang Ⅱ) and nuclear factor kappa B (NF-
κ
B) were measured. In addition, the safety was evaluated.
Result
2
Compliance rate of blood pressure in observation group was 94.74%(54/57), higher than 80.70% (46/57) in control group (
χ
2
=5.211,
P
<
0.05). Levels of 4 h SBP, 24 h DBP, 24 h PP, 24 h SSD, 24 h DSD, nSCV, nDCV, Hcy, CysC, AngⅡ, and NF-
κ
B in observation group were all lower than those detected from control group (
P
<
0.01). Score of syndrome of phlegm dampness accumulation was lower than that in control group (
P
<
0.01). Levels of UA, TC, TG, LDL-C and HOMA-IR were lower than those in control group (
P
<
0.05), while level of HDL-C was higher than that detected from control group (
P
<
0.05).
Conclusion
2
Based on lifestyle and western medicine intervention, Wendantang combined with Xueyaping recipe can further control the blood pressure level, reduce the symptoms of phlegm dampness retention syndrome, improve blood pressure variability, improve the compliance rate of blood pressure, improve the metabolism of patients and reduce the risk factors of ASCVD in middle aged and young people with hypertension.
YOU Y , WANG J , TENG W , et al . Blood pressure and noncommunicable diseases in middle-aged and older adults in China [J]. PLoS One , 2018 , 13 ( 11 ): e0206635 .
MARTELL-CLAROS N , GALGO-NAFRIA A , OPENJOVEN STUDY GROUP . Cardiovascular risk profile of young hypertensive patients: the OPENJOVEN study [J]. Eur J Prev Cardiol , 2012 , 19 ( 3 ): 534 - 540 .
YANO Y , NEELAND I J , AYERS C , et al . Hemodynamic and mechanical properties of the proximal aorta in young and middle-aged adults with isolated systolic hypertension: the dallas heart study [J]. Hypertension , 2017 , 70 ( 1 ): 158 - 165 .
XIONG X , WANG P , LI X , et al . The effects of red yeast rice dietary supplement on blood pressure, lipid profile, and C-reactive protein in hypertension: a systematic review [J]. Crit Rev Food Sci Nutr , 2017 , 57 ( 9 ): 1831 - 1851 .
NISHIO S , MARUYAMA Y , SUGANO N , et al . Gender interaction of uric acid in the development of hypertension [J]. Clin Exp Hypertens , 2018 , 40 ( 5 ): 446 - 451 .
TAO L X , YANG K , WU J , et al . Association between plasma homocysteine and hypertension: results from a cross-sectional and longitudinal analysis in Beijing's adult population from 2012 to 2017 [J]. J Clin Hypertens (Greenwich) , 2018 , 20 ( 11 ): 1624 - 1632 .
MA J , WU Z , ZHA X , et al . The combined effect of serum cystatin C and dyslipidemia on hypertension in a large health check-up population in China [J]. Clin Exp Hypertens , 2019 , 41 ( 8 ): 702 - 707 .
GAN Z , HUANG D , JIANG J , et al . Captopril alleviates hypertension-induced renal damage, inflammation, and NF- κ B activation [J]. Braz J Med Biol Res , 2018 , 51 ( 11 ): e7338 .
Effect of Bushen Huoxue Decoction to Blood Pressure Variability and Quality of Life of Patients with Kidney Deficiency and Blood Stasis-type Hypertension
Mechanism of Wendantang in Intervention of ApoE-/- Hyperlipidemic Mice Based on Liver Metabolomics
Efficacy of Fufang Lingjiao Jiangya Pills with Different Proportions of Goat Horn Replacing Antelope Horn on Spontaneous Hypertensive Rats
Characterization of Animal Models of Type 2 Diabetes Mellitus with Hypertension Based on Clinical Symptoms in Traditional Chinese and Western Medicine
Wendantang Regulates Energy Metabolism in Treatment of Myocardial Ischemia via SIRT3/PGC-1α Pathway
Related Author
TENG Ying-hua
XIE Rui
SHI Xian-zhi
ZHOU Yun
YU Songren
ZHANG Lu
LIN Wenting
YU Keming
Related Institution
Research Center for Differentiation and Development of Traditional Chinese Medicine (TCM) Basic Theory/Jiangxi Province Key Laboratory of Biological Etiologies of TCM/First-Level Discipline Platform of Chinese and Western Integrative Medicine/Experimental Animal and Scientific Technology Center of Jiangxi University of Chinese Medicine/School of Pharmacy, Jiangxi University of Chinese Medicine
School of Pharmaceutical Sciences, Zhejiang Chinese Medical University
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine